Hashtag
Men's Weekly

Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb

Cision

SAN DIEGO, SHANGHAI and SYDNEY, Feb. 6, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") announced that the U.S. Food and Drug Administration (FDA) recently granted the initial investigational new drug (IND) application for its drug candidate IMG-008, a long-acting anti-IL-36R antibody with enhanced half-life and exposure.

IMG-008, a...

Read more: Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb

More Articles ...

  1. Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
  2. BLUETTI Helps Create the Best Valentine's Day Experience
  3. Dombbit launches Self-Recharged Crypto Miner
  4. HOSPITALITY TECH PROVIDER REDCAT TOUCHES DOWN IN THE UK
  5. Quest Global Teams with NVIDIA to Build Next-Gen Omniverse Digital Twin Solutions for Manufacturing Industry

Health & Wellness

Why Regular Visits to a Trusted Dentist Matter More Than You Think

Hashtag.net.au - avatar Hashtag.net.au

Seeing a dentist is often associated with pain or emergency situations. However, routine dental visits play a much larger role in maintaining not only oral health but your overall wellbeing. Whether...

5 Signs Your Loved One Might Benefit from In-Home Therapy Support

Hashtag.net.au - avatar Hashtag.net.au

Living with a disability or health condition can present daily challenges, especially when accessing regular therapy support outside the home. That’s why many individuals and their families are turn...

Connecting You to Community: The Role of Your NDIS Disability Services Provider in Inclusion

Hashtag.net.au - avatar Hashtag.net.au

(Source)When discussing disability services, it is tempting to focus on the practical aspects, such as daily routines, mobility aids, and support workers. However, after all that, there is another thi...